Projects per year
Personal profile
Education
- 2011 PhD, Institute of Biopharmaceutical Sciences, National Cheng Kung University
Experience
- 2018/02 ~ present Associate Professor, School of Pharmacy, National Cheng Kung University
- 2018/02 ~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
- 2014/08 ~ 2018/02 Assistant Professor, School of Pharmacy, National Cheng Kung University
- 2013/02 ~ 2018/02 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
- 2011 ~ 2013 Postdoctoral Fellow, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF)
Research Interests
- Pharmacogenomics
- Human Microbiome
- Personalized Medicine
- Bioinformatics
- Clinical pharmacy
Fingerprint Dive into the research topics where Hui-Hua Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 6 Finished
補充微量營養素影響抗癲癇藥物之治療成效-影響抗癲癇藥物與綜合維生素補充劑療效之藥物基因體學研究–以維生素B6為例聯結癲癇病人基因型分析與斑馬魚活體測試之前導型研究(1/3)
17-08-01 → 18-07-31
Project: Research project
Research Output
Association between polymorphisms of OCT1 and metabolic response to metformin in women with polycystic ovary syndrome
Chang, H. H., Hsueh, Y. S., Cheng, Y. W., Ou, H. T. & Wu, M. H., 2019 Apr 1, In : International journal of molecular sciences. 20, 7, 1720.Research output: Contribution to journal › Article
Open Access
3
Citations
(Scopus)
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
Hsueh, Y. S., Chang, H. H., Shan, Y. S., Sun, H. S., Fletcher, J. A., Li, C. F. & Chen, L. T., 2019 Sep 19, In : Oncogene. 38, 38, p. 6550-6565 16 p.Research output: Contribution to journal › Article
Open Access
The interaction of oxytocin and social support, loneliness, and cortisol level in major depression
Tsai, T. Y., Tseng, H. H., Chi, M. H., Chang, H. H., Wu, C. K., Yang, Y. K. & Chen, P. S., 2019 Jan 1, In : Clinical Psychopharmacology and Neuroscience. 17, 4, p. 487-494 8 p.Research output: Contribution to journal › Article
Open Access
The OXTR polymorphism stratified the correlation of oxytocin and glucose homeostasis in non-diabetic subjects
Chang, H. H., Chang, W. H., Chi, M. H., Peng, Y. C., Huang, C. C., Yang, Y. K. & Chen, P. S., 2019 Jan 1, In : Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 12, p. 2707-2713 7 p.Research output: Contribution to journal › Article
Open Access
Factors related to metabolic parameters in medicated patients with major depressive disorder––a naturalistic study
Lee, C. J., Lee, L. T., Tsai, H. C., Chang, W. H., Lee, I. H., Chen, K. C., Chang, H. H., Chen, P. S. & Yang, Y. K., 2018 Oct, In : Psychiatry Research. 268, p. 28-33 6 p.Research output: Contribution to journal › Article
Thesis
FGF21 and LEPR polymorphisms predict valproate treatment outcome in patients with bipolar II disorder
Author: 詠文, 鄭., 2018 Apr 30Supervisor: Chang, H. (Supervisor)
Student thesis: Master's Thesis
Plasma oxytocin level and OXTR predict antidepressant treatment outcome in patients with major depressive disorder
Author: 宜靖, 彭., 2016 Aug 18Supervisor: Chang, H. (Supervisor)
Student thesis: Master's Thesis
Predicting factors for valproate treatment outcome among bipolar II patients – focused on GNB3 and CRP level
Author: 俊頡, 李., 2015 Jul 6Supervisor: Chang, H. (Supervisor)
Student thesis: Master's Thesis